Peanut Group for Cognition

Phase-Based Progress Estimates
Loma Linda University School of Public Health, Loma Linda, CA
Cognition+1 More
Habitual Diet - Other
All Sexes
What conditions do you have?

Study Summary

The study will test the effects of Peanuts on task-related brain activation and cognitive functions in older adults with memory complaints.

Eligible Conditions

  • Cognition
  • Inflammation

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 2 Secondary · Reporting Duration: baseline to 12 weeks

baseline to 12 weeks
Change in serum brain-derived neurotrophic factor (pg/mL)
changes from baseline in Brian activation
changes from baseline in global cognitive composite score
changes from baseline serum markers of inflammation

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Peanut Group
1 of 2
Control Group
1 of 2
Active Control

30 Total Participants · 2 Treatment Groups

Primary Treatment: Peanut Group · No Placebo Group · N/A

Peanut Group
ActiveComparator Group · 1 Intervention: Peanuts · Intervention Types: DietarySupplement
Control Group
ActiveComparator Group · 1 Intervention: Habitual Diet · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline to 12 weeks

Trial Background

Prof. Sujatha Rajaram, Professor
Principal Investigator
Loma Linda University
Closest Location: Loma Linda University School of Public Health · Loma Linda, CA
2016First Recorded Clinical Trial
1 TrialsResearching Cognition
2 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have two or more cardiovascular risk factors.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.